About 16 Trademarks found that are owned by Genexine Inc.

Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunomodulators; viral vaccines; pharmaceutical preparations for the treatment of viral diseases; vaccines; vaccine preparations; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases of cancer patients; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors

Research and development of vaccines and medicines; development of new cell therapy products for others; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; Pharmaceutical drug development services; inspection of pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; research on the subject of pharmaceuticals; clinical research in the field of medicine; consultancy pertaining to pharmacology; medical laboratories; medical research laboratory services; medical research laboratory services for predicting disease; medicine research; testing of pharmaceuticals

DNA vaccines; preventive vaccines; pharmaceutical preparations for gene therapy; drugs for medical purposes, namely, pharmaceutical drug preparations for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of head and neck cancer; injectable pharmaceuticals for medical purposes, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; pharmaceutical preparations for immunomodulatory purposes, namely, for the regulation of immune functions; pharmaceutical preparations for the treatment of cervical cancer; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for the treatment of cervical pre-cancer; vaccines; therapeutic vaccines; pharmaceutical products and preparations, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; dermatological pharmaceutical products; antiviral agent against human papilloma virus; preventive vaccines against human papilloma virus infections; pharmaceutical preparations for anticancer immunotherapy; anti-cancer preparations; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia

Pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; vaccines; adjuvants for use with vaccines; vaccine preparations; anti-inflammatories; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; nucleic acid sequences for medical and veterinary purposes; diagnostic preparations for medical purposes for detecting mutation in prion genes; chemical preparations for use in DNA analysis for medical purposes; reagents for use in medical genetic testing; human vaccine preparations; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of immune system related diseases and disorders; anti-asthmatic agents, namely, pharmaceutical preparations for the treatment of asthmatic disorders; dermatological pharmaceutical products; antibiotic preparations; biological preparations, namely, antibody fusion proteins for the treatment of cancer

Research and development of vaccines and medicines; crude medicines research; research on adult diseases; bacteriological research; research on cancer; pharmaceutical products development; pharmaceutical products research; pharmaceutical products evaluation; consultancy pertaining to pharmacology; medical product testing; research for medical products; medical research; clinical trials; research and development of DNA chips; structural and functional analysis of genomes; biotechnology research; advisory services relating to biotechnology; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; testing/inspection or research on pharmaceuticals/cosmetics or food

Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of short bowel syndrome; Pharmaceutical agents for treatment of diabetes; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of rheumatoid arthritis; vaccines; pharmaceutical preparations for the treatment of anemia; fungicides; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations for the treatment of cardiovascular disorders; medicated candy; Pharmaceutical preparations to treat HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; pharmaceutical preparations for the treatment of inflammatory bowel disease; Pharmaceutical preparations being pills for inflammation treatment; pharmaceutical preparations for the treatment of dwarfism; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of systemic lupus erythematosus; Pharmaceutical agents for treating asthma, Pharmaceutical agents for the treatment of asthma; dermatological pharmaceutical products; antibiotic preparations; antibiotics; anti-cancer preparations; Antibody fusion protein for medical treatment in the nature of pharmaceutical preparations for the treatment of HPV type 16 and/or 18 caused Precancerous Dysplasia and Cancer; blood solvent, namely, blood plasma; pharmaceutical preparations for the treatment of neutropenia

The mark consists of a stylized design consisting of two ovals connected by 5 lines to two more ovals that are divided, and are stacked above two other ovals. To the right of the stylized design are the letters "hyFc" stacked above the word "technology".

Laboratory research services relating to pharmaceuticals; Research for medical products; Providing information on the testing, inspection, and research of medical products; Scientific research consulting services in the field of medical products; Drug discovery services; Research and development in the field of peptides for medical purposes

Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; medicines for the treatment of cardiovascular and cerebrovascular diseases; pills for dizziness symptoms treatment being pharmaceutical preparations for the treatment of dizziness; biological preparations for medical purposes being biological preparations for the treatment of anemia, kidney disease and kidney disorders; cardiovascular agents for medical purposes; drugs for medical purposes being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; synthetic peptides for pharmaceutical purposes being synthetic peptides for the treatment of anemia, kidney disease and kidney disorders; pharmaceuticals being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; medicines for human purposes being pharmaceutical preparations for the treatment of anemia, kidney disease and kidney disorders; anemia treatment medicines that stimulate red blood cell production being pharmaceutical preparations for the treatment of anemia; medicines to stimulate red blood cell production being pharmaceutical preparations for the treatment of anemia; pharmaceutical preparations for treatment of chronic kidney disease and anemia; biological preparations for treatment of anemia; biological preparations to stimulate red blood cell production for veterinary and medical purposes being biological preparations for the treatment of anemia; synthetic peptides for pharmaceutical and anemia treatment purposes being synthetic peptides for the treatment of anemia; synthetic peptides for pharmaceutical and kidney disease treatment purposes being synthetic peptides for the treatment of kidney disease

The mark consists of a stylized design consisting of two ovals connected by 5 lines to two more ovals that are divided, and are stacked above two other ovals. To the right of the stylized design are the letters "hyFc" stacked above the word "technology".